CROSS HERB
Insider CIK 1230721 · AFFY Chief Financial Officer · KBIO Chief Financial Officer · BCEL Chief Financial Officer · ARMO Chief Financial Officer · JSPR Chief Financial Officer · APGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-09-22 | 2023-09-26 | 550,000 | — | $0 | 550,000 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 5,487 | $0.95 | $5.2K | 72,817 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 175,000 | — | $0 | 175,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award | 2023-02-09 | 2023-02-13 | 43,750 | — | $0 | 78,304 | SEC↗ |
| APGN Apexigen, Inc. | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCEL Atreca, Inc. | S Sale | 2022-09-02 | 2022-09-20 | 7,646 | $1.78 | $13.6K | 34,554 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 95,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 95,000 | — | $0 | 95,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 224,999 | — | $0 | 224,999 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 224,999 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 97,000 | — | $0 | 97,000 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 97,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-12-23 | 2021-12-28 | 95,000 | — | $0 | 95,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award | 2021-09-09 | 2021-09-13 | 42,200 | — | $0 | 42,200 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-01-27 | 2021-01-29 | 95,000 | — | $0 | 95,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-02-26 | 2020-02-28 | 97,000 | — | $0 | 97,000 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | D To issuer deriv | 2018-06-22 | 2018-06-22 | 240,658 | $43.03 | $10.36M | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-11-09 | 2015-11-10 | 1,875 | — | $0 | 1,875 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-10-08 | 2015-10-08 | 1,875 | — | $0 | 1,875 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-09-08 | 2015-09-22 | 1,875 | — | $0 | 1,875 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-08-10 | 2015-08-11 | 1,875 | — | $0 | 1,875 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-07-07 | 2015-07-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-06-08 | 2015-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-05-07 | 2015-05-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-04-07 | 2015-04-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-03-10 | 2015-03-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-02-16 | 2015-02-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-02-06 | 2015-02-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-01-20 | 2015-01-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-01-20 | 2015-03-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-10-22 | 2013-10-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2013-01-30 | 2013-02-01 | 5,000 | — | $0 | 21,370 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-05 | 2012-09-07 | 5,000 | — | $0 | 55,000 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-09-05 | 2012-09-07 | 5,000 | $18.50 | $92.5K | 11,293 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-05 | 2012-09-07 | 5,000 | $7.99 | $40.0K | 16,293 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-07-17 | 2012-07-17 | 10,000 | — | $0 | 40,000 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-07-17 | 2012-07-17 | 10,000 | $17.00 | $170.0K | 10,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-07-17 | 2012-07-17 | 10,000 | $6.23 | $62.3K | 20,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-07-13 | 2012-07-17 | 15,000 | — | $0 | 45,000 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-07-13 | 2012-07-17 | 15,000 | $15.50 | $232.5K | 10,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-07-13 | 2012-07-17 | 15,000 | $5.10 | $76.5K | 25,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-01-31 | 2012-02-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2012-01-31 | 2012-02-02 | 10,000 | — | $0 | 10,000 | SEC↗ |